Passaworn Cheyasawan

Neutralizing Antibody and T-Cell Responses against SARS-CoV-2 Wild-Type and Variants of Concern in Chronic Obstructive Pulmonary Disease Subjects after ChAdOx-1/ChAdOx-1 Homologous Vaccination: A Preliminary Study

C. Bumroongkit, W. Kasinrerk, S. Pata, 2022, Vaccines.

Neutralizing antibody and T-cell responses against SARS-CoV-2 variants by heterologous CoronaVac/ChAdOx-1 vaccination in elderly subjects with chronic obstructive pulmonary disease.

C. Bumroongkit, W. Kasinrerk, S. Pata, 2023, Vaccine.

The ligation of CD4 molecules, expressed on monocytes by an anti-CD4 monoclonal antibody, inhibits T cell activation and monocyte mobility.

W. Kasinrerk, S. Pata, Witida Laopajon, 2023, Asian Pacific journal of allergy and immunology.